- Home
- BMY vs RELX Comparison
BMY vs RELX Comparison
Compare BMY & RELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- RELX
- Stock Information
- Founded
- BMY 1887
- RELX 1903
- Country
- BMY United States
- RELX United Kingdom
- Employees
- BMY N/A
- RELX N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- RELX Business Services
- Sector
- BMY Health Care
- RELX Consumer Discretionary
- Exchange
- BMY Nasdaq
- RELX Nasdaq
- Market Cap
- BMY 120.5B
- RELX 100.9B
- IPO Year
- BMY N/A
- RELX N/A
- Fundamental
- Price
- BMY $46.98
- RELX $55.03
- Analyst Decision
- BMY Hold
- RELX Strong Buy
- Analyst Count
- BMY 16
- RELX 2
- Target Price
- BMY $58.93
- RELX N/A
- AVG Volume (30 Days)
- BMY 15.8M
- RELX 793.0K
- Earning Date
- BMY 04-24-2025
- RELX 07-24-2025
- Dividend Yield
- BMY 5.28%
- RELX 1.01%
- EPS Growth
- BMY N/A
- RELX 10.15
- EPS
- BMY 2.67
- RELX 1.29
- Revenue
- BMY $47,636,000,000.00
- RELX $11,810,658,884.00
- Revenue This Year
- BMY N/A
- RELX $9.12
- Revenue Next Year
- BMY N/A
- RELX $7.22
- P/E Ratio
- BMY $17.59
- RELX $42.28
- Revenue Growth
- BMY 4.62
- RELX 2.98
- 52 Week Low
- BMY $39.35
- RELX $43.28
- 52 Week High
- BMY $63.33
- RELX $56.33
- Technical
- Relative Strength Index (RSI)
- BMY 42.78
- RELX 59.23
- Support Level
- BMY $46.47
- RELX $54.54
- Resistance Level
- BMY $47.36
- RELX $56.33
- Average True Range (ATR)
- BMY 1.20
- RELX 0.53
- MACD
- BMY 0.32
- RELX -0.01
- Stochastic Oscillator
- BMY 67.42
- RELX 74.21
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About RELX RELX PLC PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.